Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Learn more about Martina and her recap of 2022 at GenomSys and her outlook for 2023 for herself and the company through the following quick questions:

Happy New Year Martina. Starting of easy, which fun-fact did you learn this year?

I don’t know why I was so surprised at the beginning, but in 2022 I discovered that the DNA contains all the useful information for the identification of a match for a blood donor. Sometimes the logic is blurred by everyday use.

What was your most outstanding achievement at GenomSys in 2022?

I think the most outstanding achievement for the team in 2022 is the fact that we defined our purpose in genomics. We determined GenomSys’ position and the leitmotif of our products, differentiating ourselves from competitors in the genomic field. From a human perspective, I believe that in 2022 we faced a challenging situation as the team grew very fast, and some roles went through a review of responsibilities. However, the team was able to stick together and build an even more profound relationship in order to reach our ambitious goals in 2023.

What was the most important thing you learned in 2022?

Similarly to 2021, it is difficult for me to pick the single most important thing I’ve learned during a whole year. As a personal achievement, I am happy I had the opportunity to work on new ISO standards that required me to get out of my comfort zone and grow professionally and personally.

What are your expectations for you and/or GenomSys for 2023?

2023 should be the breakthrough of GenomSys. I hope we will be able to close some important deals with partners around the globe to be able to differentiate our commercial strategies. I’m expecting the team to provide innovative solutions that can attract the interest of these new partners and that this will lead to the improvement of the process obtaining relevant information for the treatment and diagnosis of patients.

If you have any further questions for Martina or about GenomSys, please feel free to contact us.

Schedule a call

[contact-form-7 id="224" title="contact call"]